Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07WJE
|
|||
| Former ID |
DIB004633
|
|||
| Drug Name |
NVC-422
|
|||
| Synonyms |
AgaNase; AL-46383A; NVC-422; Aganocides (infection), NovaBay; NVC-422 (skin infections), NovaBay; Aganocides (lavage solution, urinary tract infections/bacterial infections), NovaBay; NVC-422 (lavage solution, urinary tract infections), NovaBay; NVC-422 (nasal, infection prevention), NovaBay; NVC-422 (nasal, infection prevention), NovaCal; Aganocides (ear/eye/sinus infection), NovaBay/Alcon; N,N-dichloro-2-2-dimethyltaurine; NVC-422 (topical, skin infections), NovaBay/Galderma; NVC-422 (ophthalmic/otic, ear/eye/sinus infection), NovaBay; NVC-422 (ophthalmic/otic, ear/eye/sinus infection), NovaBay/Alcon
Click to Show/Hide
|
|||
| Indication | Infectious disease [ICD-11: 1A00-CA43.1; ICD-9: 001-139] | Phase 2/3 | [1] | |
| Company |
NovaBay Pharmaceuticals Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027530) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.